PATHOGENETIC EFFECTS OF COMBINATION THERAPY IN THE TREATMENT OF COMORBID PATHOLOGY

  • P. Herych Ivano-Frankivsk National Medical University
  • I. Popadynets Ivano-Frankivsk National Medical University
  • R. Yatsyshyn Ivano-Frankivsk National Medical University
  • V. Mygovych Ivano-Frankivsk National Medical University
  • V. Kaminskyi Ivano-Frankivsk National Medical University
Keywords: stable ischemic heart disease; chronic obstructive pulmonary disease; endothelial dysfunction; oxidative stress.

Abstract

The objective of the work was to determine the possibility of drug correction of endothelial dysfunction, structural changes in peripheral arteries and the synthesis of end products of nitric oxide metabolism by the use of a combination of roflumilast and quercetin in the baseline therapy. In contrast to the baseline, the use of integrated therapy was followed in 6 months by a probable increase in the initial rate by 18.76 % (0.61 ± 0.04) m/s to (0.75 ± 0.04) m/s (t = 2.47; P < 0.05) and a probable decrease in the initial diameter of the brachial artery to (3.69 ± 0.29) mm (t = 2.49; P < 0.05). Patients of the experimental group have shown a significant increase in mean values of EDVD at the end of in-patient treatment and after 6 months of intensive supportive therapy (t = 2.17; Р < 0.05). The appointment of complex therapy after 6 months showed an increase in concentration in the blood of metabolites of NO in 1,3 times to (10.35 ± 1.89) μmol/l (t = 1.00; P > 0.1) at normal (12.05 ± 2.11) μmol/l. In patients of the index group after six months of the background therapy, IMT index has appeared in 1.07 times lower than the input data and has not reached the level of the control group. The IMT index for patients in the experimental group was considerably lower than the index before treatment (t = 0.31; P > 0.1).  Application of complex therapy in patients with severe chronic obstructive pulmonary disease in the exacerbation phase in combination with stable coronary heart disease, stable angina pectoris I–II FK contributes to the restoration of endothelial function, improves structural changes in the peripheral arteries and has a stimulating effect on the synthesis of nitric oxide.

Downloads

Download data is not yet available.

References

Berezin A. E. Proteiny vnekletochnogo matriksa kak biomarkyory vaskulyarnogo remodelirovaniya i kardiovaskulyarnyh klinicheskih iskhodov // Ukr. med. chasopis. – 2015. – Vyp. 110, № 6. – Р. 58–64.

Berezin A. E. Terapevticheskij potencial α-lipoevoj (tioktovoj) kisloty pri kardiovaskulyarnyh zabolevaniyah // Ukr. med. chasopis. – 2017. – Vyp. 118, № 2. – Р. 95–98.

Ivanova O. V., Balahonova T. V., Soboleva G. N. Sostoyanie endotelijzavisimoj vazodilatacii plechevoj arterii u bol'nyh gipertonicheskoj bolezn'yu, ocenivaemoe s pomoshch'yu ul'trazvuka vysokogo razresheniya // Kardiologiya. – 1997. – № 7. – Р. 41–46.

Kuperberg E. B., Gajdashev A. E., Lavrent'ev A. V. Klinicheskaya dopplerografiya okklyuziruyushchih porazhenij arterij mozga i konechnostej: Ucheb.-metod. rukovodstvo. – M.: Izd-vo NCSSKH RAMN im. A. N. Bakuleva, 1997. – 236 р.

Nakaz MOZ Ukraїni za № 152 «Unіfіkovanij klіnіchnij protokol pervinnoї, vtorinnoї (specіalіzovanoї) ta tretinnoї (visokospecіalіzovanoї) medichnoї dopomogi «Stabіl'na іshemіchna hvoroba sercya» vіd 02.03.2016 r.

Nakaz MOZ Ukraїni za № 555 «Unіfіkovanij klіnіchnij protokol pervinnoї, vtorinnoї (specіalіzovanoї), tretinnoї (visokospecіalіzovanoї) medichnoї dopomogi ta reabіlіtacії «Hronіchne obstruktivne zahvoryuvannya legenі» vіd 27.06.2013 r.

Amanda Sampaio Storch, João Dario de Mattos, Renata Alves et al. Methods of Endothelial Function Assessment: Description and Applications // International Journal of Cardiovascular Sciences. – 2017. – Vol. 30, N 3. – P. 262–272.

Astuti R. I., Nasuno R., Takagi H. Nitric oxide signaling in yeast // Appl. Microbiol. Biotechnol. – 2016. – Vol. 100, N 22. – Р. 9483–9497.

Byon C. H., Heath J. M., Chen Y. Redox signaling in cardiovascular pathophysiology: a focus on hydrogen peroxide and vascular smooth muscle cells // Redox. Biol. – 2016. – Vol. 9. – P. 244–253.

Chen Z., Liu X., Ma S. The Roles of Mitochondria in Autophagic Cell Death // Cancer Biother. Radiopharm. – 2016. – Vol. 31, N 8. – P. 269–276.

Celermajer D., Sorensen K., Gooch V. et al. Non-in vasive detection of endothelial dysfunction in children an adults at risk of atherosclerosis // Lancet. – 1992. – Vol. 340. – P. 1111–1115.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Pocket guide to COPD diagnosis, management, and prevention: a guide for health care professionals. – 2018. – http://www.goldcopd.org

Gnudi L., Coward R. J., Long D. A. Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms. Trends Endocrinolog // Metab. – 2016. – Vol. 27, N 11. – P. 820–830.

Kurundkar A., Thannickal V. J. Redox mechanisms in age-related lung fibrosis // Redox. Biol. – 2016. – Vol. 9. – P. 67–76.

Redza-Dutordoir M., Averill-Bates D. Activation of apoptosis signalling pathways by reactive oxygen species // Biochim. Biophys. Acta. – 2016. – Vol. 1863, N 12. – P. 2977–2992.

Regina C., Panatta E., Candi E. et al. Vascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseases // Mech. Ageing Dev. – 2016. – Vol. 159. – P. 14–21.

Zhu J., Wang H., Chen F. et al. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy // Free Radic. Biol. Med. – 2016. – Vol. 99. – P. 544–556.


Abstract views: 93
PDF Downloads: 83
Published
2019-06-16
How to Cite
Herych, P., Popadynets, I., Yatsyshyn, R., Mygovych, V., & Kaminskyi, V. (2019). PATHOGENETIC EFFECTS OF COMBINATION THERAPY IN THE TREATMENT OF COMORBID PATHOLOGY. Likarsʹka Sprava, (4), 29-35. https://doi.org/10.31640/JVD.4.2019(5)
Section
Guide lines for the practitioner